May 28, 2025 Alcon announced the U.S. Food and Drug Administration (FDA) approved TRYPTYR® (acoltremon ophthalmic solution) 0,003%, formerly known as AR-15512, for the treatment of signs and symptoms of Dry Eye Disease. “In clinical trials,…
Bausch + Lomb Corporation announced, during April 2024, the U.S. Food and Drug Administration (FDA) approved LUMIFY® Preservative Free redness reliever eye drops, the first and only over-the-counter preservative-free eye drop with low-dose OTC brimonidine tartrate…
The Eye Care Institute, and our sister company, Butchertown Clinical Trials, proudly announce that we have been named a Top Workplace in Kentucky by the Kentucky Chamber of Commerce and…
LOUISVILLE, KENTUCKY, UNITED STATES, March 11, 2024 /EINPresswire.com/ — Formosa Pharmaceuticals, Inc., Songshan Dist., Taipei City 105, Taiwan, announced the U.S. Food and Drug Administration (FDA) approved Clobetasol propionate ophthalmic suspension,…
Orasis Pharmaceuticals Announces FDA Approval of QLOSI™ (pilocarpine hydrochloride ophthalmic solution) 0.4% for the Treatment of Presbyopia Ponte Vedra, FL, October 18, 2023 QLOSI (pronounced CLOH-see) is a prescription eye…